814
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Spray-dried nanocrystal-loaded polymer microparticles for long-term release local therapies: an opportunity for poorly soluble drugs

, , , , &
Article: 2284683 | Received 05 Jun 2023, Accepted 12 Nov 2023, Published online: 22 Nov 2023

References

  • Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:1–14. doi: 10.1023/A:1016212804288.
  • Barbosa-Alfaro D, Andrés-Guerrero V, Fernandez-Bueno I, et al. (2021). Dexamethasone PLGA microspheres for sub-tenon administration: influence of sterilization and tolerance studies. Pharmaceutics 13:228. doi: 10.3390/PHARMACEUTICS13020228.
  • Bodratti AM, Alexandridis P. (2018). Formulation of poloxamers for drug delivery. J Funct Biomater 9:11. doi: 10.3390/JFB9010011.
  • Bonhoeffer B, Kordikowski A, John E, Juhnke M. (2022). Numerical modeling of the dissolution of drug nanocrystals and its application to industrial product development. Admet DMPK 10:253–87. doi: 10.5599/ADMET.1437.
  • Ferrar JA, Sellers BD, Chan C, Leung DH. (2020). Towards an improved understanding of drug excipient interactions to enable rapid optimization of nanosuspension formulations. Int J Pharm 578:119094. doi: 10.1016/J.IJPHARM.2020.119094.
  • Gonzalez-Fernandez P, Rodríguez-Nogales C, Jordan O, Allémann E. (2022). Combination of mesenchymal stem cells and bioactive molecules in hydrogels for osteoarthritis treatment. Eur J Pharm Biopharm 172:41–52. doi: 10.1016/J.EJPB.2022.01.003.
  • Han FY, Thurecht KJ, Whittaker AK, Smith MT. (2016). Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading. Front Pharmacol 7:185. doi: 10.3389/FPHAR.2016.00185.
  • Hunter DJ, Bierma-Zeinstra S. (2019). Osteoarthritis. Lancet 393:1745–59. doi: 10.1016/S0140-6736.(19)30417-9.
  • Jermain SV, Brough C, Williams RO. (2018). Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – An update. Int J Pharm 535:379–92. doi: 10.1016/J.IJPHARM.2017.10.051.
  • Kojima Y, Ohta T, Shiraki K, et al. (2013). Effects of spray drying process parameters on the solubility behavior and physical stability of solid dispersions prepared using a laboratory-scale spray dryer. Drug Dev Ind Pharm 39:1484–93. doi: 10.3109/03639045.2012.692378.
  • Lindfors L, Forssén S, Westergren J, Olsson U. (2008). Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interface Sci 325:404–13. doi: 10.1016/J.JCIS.2008.05.034.
  • Malamatari M, Taylor KMG, Malamataris S, et al. (2018). Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discov Today 23:534–47. doi: 10.1016/J.DRUDIS.2018.01.016.
  • Maudens P, Jordan O, Allémann E. (2018a). Recent advances in intra-articular drug delivery systems for osteoarthritis therapy. Drug Discov Today 23:1761–75. doi: 10.1016/J.DRUDIS.2018.05.023.
  • Maudens P, Seemayer CA, Pfefferlé F, et al. (2018b). Nanocrystals of a potent p38 MAPK inhibitor embedded in microparticles: therapeutic effects in inflammatory and mechanistic murine models of osteoarthritis. J Control Release 276:102–12. doi: 10.1016/J.JCONREL.2018.03.007.
  • Maudens P, Seemayer CA, Thauvin C, et al. (2018c). Nanocrystal–polymer particles: extended delivery carriers for osteoarthritis treatment. Small 14:1703108. doi: 10.1002/SMLL.201703108.
  • Meeus J, Chen X, Scurr DJ, et al. (2012). Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone. J Pharm Sci 101:3473–85. doi: 10.1002/JPS.23131.
  • Nandiyanto ABD, Okuyama K. (2011). Progress in developing spray-drying methods for the production of controlled morphology particles: From the nanometer to submicrometer size ranges. Adv Powder Technol 22:1–19. doi: 10.1016/j.apt.2010.09.011.
  • Paik J, Duggan ST, Keam SJ. (2019). Triamcinolone acetonide extended-release: a review in osteoarthritis pain of the knee. Drugs 79:455–62. doi: 10.1007/s40265-019-01083-3.
  • Paudel A, Worku ZA, Meeus J, et al. (2013). Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm 453:253–84. doi: 10.1016/J.IJPHARM.2012.07.015.
  • Phillips DJ, Pygall SR, Cooper VB, Mann JC. (2012). Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems. J Pharm Pharmacol 64:1549–59. doi: 10.1111/J.2042-7158.2012.01523.X.
  • Pradal J, Maudens P, Gabay C, et al. (2016). Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice. Int J Pharm 498:119–29. doi: 10.1016/J.IJPHARM.2015.12.015.
  • Salgado C, Guénée L, Černý R, et al. (2020). Nano wet milled celecoxib extended release microparticles for local management of chronic inflammation. Int J Pharm 589:119783. doi: 10.1016/J.IJPHARM.2020.119783.
  • Siepmann J, Siepmann F. (2008). Mathematical modeling of drug delivery. Int J Pharm 364:328–43. doi: 10.1016/j.ijpharm.2008.09.004.
  • Singh A, van den Mooter G. (2016). Spray drying formulation of amorphous solid dispersions. Adv Drug Deliv Rev 100:27–50. doi: 10.1016/J.ADDR.2015.12.010.
  • Sosnik A, Seremeta KP. (2015). Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. Adv Colloid Interface Sci 223:40–54. doi: 10.1016/J.CIS.2015.05.003.
  • Sotthivirat S, Ramesh R, Wasylaschuk W, et al. (2020). Effect of TPGS surfactant on dissolution sensitivity of a poorly water-soluble drug using high-shear wet granulation. Powder Technol 375:302–9. doi: 10.1016/j.powtec.2020.07.093.
  • Ting JM, Tale S, Purchel AA, et al. (2023). High-throughput excipient discovery enables oral delivery of poorly soluble pharmaceuticals. ACS Cent Sci 2:748–55. doi: 10.1021/acscentsci.6b00268.
  • van Eerdenbrugh B, van den Mooter G, Augustijns P. (2008). Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 364:64–75. doi: 10.1016/J.IJPHARM.2008.07.023.
  • Wan F, Bohr A, Maltesen MJ, et al. (2013). Critical solvent properties affecting the particle formation process and characteristics of celecoxib-loaded plga microparticles via spray-drying. Pharm Res 30:1065–76. doi: 10.1007/S11095-012-0943-X.
  • Wan F, Yang M. (2016). Design of PLGA-based depot delivery systems for biopharmaceuticals prepared by spray drying. Int J Pharm 498:82–95. doi: 10.1016/J.IJPHARM.2015.12.025.
  • Xu Y, Kim CS, Saylor DM, Koo D. (2016). Review Article Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories. J Biomed Mater Res B Appl Biomater 105:1692–716. doi: 10.1002/jbm.b.33648.